IGIM
MACK

I.G. Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

I.G. Investment Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,533
Closed -$259K – 919
2014
Q1 		$259K Buy
+6,533
New +$280K ﹤0.01% 763

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

I.G. Investment Management's MACK Position: Q2 2014 in Review

I.G. Investment Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2014, closing a stake of 6,533 shares — an estimated $259K sold.

I.G. Investment Management first reported a position in MACK in Q1 2014 and held it in 1 quarter. The position peaked at $259K in Q1 2014. 121 funds tracked by Wall St. Rank hold MACK as of Q2 2014.

  • I.G. Investment Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • I.G. Investment Management sold 6,533 Merrimack Pharmaceuticals, Inc. shares in Q2 2014, an estimated $259K.
  • I.G. Investment Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2014 and held it in 1 quarter.
  • I.G. Investment Management's Merrimack Pharmaceuticals, Inc. position peaked at $259K in Q1 2014.
  • 121 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2014.

Based on I.G. Investment Management's 13F filing for Q2 2014, filed 14 Aug 2014.